May 20 @ 6:30 pm – 8:30 pm PDT
Marriott Marquis – Marina Ballroom F/G
Supported By: Boehringer Ingelheim Pharmaceuticals, Inc.
Program Description
At this non-CME educational event, Dr. Cedric “Jamie” Rutland will explore the use of OFEV® (nintedanib) capsules, while emphasizing the importance of patient-centered care through the narrative of a patient mentor. The audience will gain insights into the pharmacology of OFEV, and Dr. Rutland will highlight key efficacy and safety data. Before the clinical data is presented, Sylvia R., a patient mentor, will share their personal journey and provide a firsthand account of their treatment with OFEV, offering a real-world perspective on the impact of OFEV.
An Industry Supported Symposium at the ATS 2024 International Conference. This evening educational program is sponsored by Boehringer Ingelheim Pharmaceuticals, Inc. open to all ATS 2024 International Conference attendees.
This is a non-CME event and does not qualify for CME or CE credit. Onsite registration/admission will occur for conference registrants only at the symposium entrance, on a first-come, first-serve basis.
Presentation content has been reviewed for consistency with FDA guidelines and is not approved for continuing medical education credit. Speakers receive fair market value compensation for this presentation. Aspects of this program may be reportable under the Physicians Payment Sunshine Act. Pursuant to the PhRMA (Pharmaceutical Research and Manufacturers of America) Code on Interactions with Healthcare Professionals, attendance at this promotional program is limited to healthcare professionals, attendance by healthcare professionals’ spouses or guests is not permitted.
Speakers
Presenter: Cedric “Jamie” Rutland, MD
Rutland Medical Group
CEO and Medical Director
Riverside, California